Cargando…
Nuclear Factor-Kappa B Inhibition Can Enhance Apoptosis of Differentiated Thyroid Cancer Cells Induced by (131)I
OBJECTIVE: To evaluate changes of nuclear factor-kappa B (NF-κB) during radioiodine 131 ((131)I) therapy and whether NF-κB inhibition could enhance (131)I-induced apoptosis in differentiated thyroid cancer (DTC) cells in a synergistic manner. METHODS: Three human DTC cell lines were used. NF-κB inhi...
Autores principales: | Meng, Zhaowei, Lou, Shanshan, Tan, Jian, Xu, Ke, Jia, Qiang, Zheng, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3306418/ https://www.ncbi.nlm.nih.gov/pubmed/22438958 http://dx.doi.org/10.1371/journal.pone.0033597 |
Ejemplares similares
-
Effect of (131)I Therapy on Complete Blood Count in Patients with Differentiated Thyroid Cancer
por: Rui, Zhongying, et al.
Publicado: (2021) -
Prediction of thyroidal (131)I effective half-life in patients with Graves' disease
por: Zhang, Ruiguo, et al.
Publicado: (2017) -
Analysis of risk factors of rapid thyroidal radioiodine-131 turnover in Graves’ disease patients
por: Zhang, Ruiguo, et al.
Publicado: (2017) -
HSA-MnO(2)-(131)I Combined Imaging and Treatment of Anaplastic Thyroid Carcinoma
por: Yan, Ziyu, et al.
Publicado: (2022) -
Radionuclide (131)I-labeled albumin-indocyanine green nanoparticles for synergistic combined radio-photothermal therapy of anaplastic thyroid cancer
por: Zhang, Xuemei, et al.
Publicado: (2022)